No, only that they billed $1.6m in FY23 and expect to bill $5.7m in FY-24 post acquisition based on unaudited management accounts and predicted additional clinical service revenues.
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
